
To report the health‐related quality of life (HRQoL) after robot‐assisted radical cystectomy and intracorporeal urinary diversion (iRARC), and to identify factors impacting on return to baseline. Consecutive patients undergoing iRARC between January 2016 and December 2017 completed the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 30‐item core (EORTC‐QLQ‐C30) and EORTC‐QLQ‐Muscle‐Invasive Bladder Cancer Module (EORTC‐QLQ‐BLM30) questionnaires before surgery and had a minimum of 12 months follow‐up postoperatively...
Like
Save
Share